Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Wednesday, January 22, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
First participants randomized in AskBio Phase II gene therapy trial for Parkinson’s disease
admin
-
January 18, 2025
Latest Pharma-News
Johnson & Johnson initiated submission of NDA application with U.S. FDA for TAR-200 for BCG-unresponsive high-risk non-muscle-invasive bladder cancer
admin
-
January 18, 2025
Latest Pharma-News
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
admin
-
March 8, 2024
Latest Pharma-News
FDA Clears First Over-the-Counter Continuous Glucose Monitor
admin
-
March 8, 2024
Latest Pharma-News
FDA, Industry Actions End Sales of PFAS Used in US Food Packaging
admin
-
March 1, 2024
Latest Pharma-News
FDA Accepts Pfizer’s sNDA for BRAFTOVI + MEKTOVI
admin
-
April 10, 2023
0
Latest Pharma-News
Sandoz receives approval by EC for Hyrimoz® high-concentration formulation
admin
-
April 6, 2023
0
Latest Pharma-News
AZ’s Lynparza and Imfinzi combination shows positive results in advanced ovarian cancer
admin
-
April 6, 2023
0
Latest Pharma-News
FDA Moves Forward with Mail-back Envelopes for Opioid Analgesics Dispensed in Outpatient Settings
admin
-
April 6, 2023
0
Latest Pharma-News
Ultomiris recommended for approval in EU for neuromyelitis optica spectrum disorder
admin
-
April 3, 2023
0
Latest Pharma-News
FDA Approves First Over-the-Counter Naloxone Nasal Spray
admin
-
March 30, 2023
0
Latest Pharma-News
License agreement with KYM Biosciences for CMG901, a Claudin-18.2 antibody drug conjugate, completed
admin
-
March 30, 2023
0
Latest Pharma-News
IOnctura Awarded UK’s MHRA Innovation Passport For Entry ILAP
admin
-
March 29, 2023
0
Latest Pharma-News
EnteroBiotix Initiates Phase 2 study of microbiome drug EBX-102 in liver cirrhosis and hepatic encephalopathy
admin
-
March 29, 2023
0
Latest Pharma-News
BMS Sotyktu approves for the Treatment of Moderate-to-Severe Plaque Psoriasis
admin
-
March 28, 2023
0
Latest Pharma-News
FDA Outlines Immediate National Strategy to Further Increase the Resiliency of U.S. Infant Formula Market
admin
-
March 28, 2023
0
Latest Pharma-News
Bayer Pharmaceuticals accelerates innovations for patients
admin
-
March 27, 2023
0
1
2
3
4
...
145
Page 3 of 145
- Advertisment -
Most Read
First participants randomized in AskBio Phase II gene therapy trial for Parkinson’s disease
January 18, 2025
Johnson & Johnson initiated submission of NDA application with U.S. FDA for TAR-200 for BCG-unresponsive high-risk non-muscle-invasive bladder cancer
January 18, 2025
What is Decentralized clinical trials?:Benefits and challenges of implementing DCT
September 23, 2024
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
March 8, 2024